Granit RZ, Masury H, Condiotti R, et al. Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer. Cell Rep. 2018;24(12):3237-3250. doi:10.1016/j.celrep.2018.08.053Google ScholarPubMedDOI

Rheinbay E, Parasuraman P, Grimsby J, et al. Recurrent and functional regulatory mutations in breast cancer. Nature. 2017;547(7661):55-60. doi:10.1038/nature22992Google ScholarPubMedDOI

Mostoslavsky R, Bardeesy N. Reprogramming Enhancers to Drive Metastasis. Cell. 2017;170(5):823-825. doi:10.1016/j.cell.2017.08.010Google ScholarPubMedDOI

Wang X, Srivastava Y, Jankowski A, et al. DNA-mediated dimerization on a compact sequence signature controls enhancer engagement and regulation by FOXA1. Nucleic Acids Res. 2018;46(11):5470-5486. doi:10.1093/nar/gky259Google ScholarPubMedDOI

Barbieri CE, Baca SC, Lawrence MS, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44(6):685-9. doi:10.1038/ng.2279Google ScholarPubMedDOI

Su Y, Subedee A, Bloushtain-Qimron N, et al. Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer. Cell Rep. 2015;11(10):1549-63. doi:10.1016/j.celrep.2015.05.011Google ScholarPubMedDOI

Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-19. doi:10.1016/j.cell.2015.09.033Google ScholarPubMedDOI

Pomerantz MM, Li F, Takeda DY, et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat Genet. 2015;47(11):1346-51. doi:10.1038/ng.3419Google ScholarPubMedDOI